Quantcast

Latest Acetylcholinesterase inhibitors Stories

2014-07-02 23:03:21

MarketReportsOnline.com adds "Alzheimer’s Disease Patients & Market Worldwide, Future Scenario (2010 – 2015) & Drugs Analysis" report to its research store. Dallas, Texas (PRWEB) July 02, 2014 Alzheimer’s is a complex disease and there is no single “magic bullet” available in the market to prevent or cure it. Though many marketed drugs have been approved for Alzheimer’s disease, it still remains a significant area of unmet medical need. Clinical success has...

2014-04-01 12:33:44

LONDON, April 1, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:Alzheimer's Pipeline Drugs Review, Alzheimer's Disease Drug Market & Forecast - Global Analysis Alzheimer's disease drug market is on the curvature stage. Since 2003, there is not any single "magic bullet" launched in the market to prevent or cure it. However, all current marketed products are going to be generic in the next 3-4 years. There are high unmet medical needs....

2014-01-09 08:28:50

EMERYVILLE, Calif., Jan. 9, 2014 /PRNewswire/ -- Adamas Pharmaceuticals, Inc. announced today that it has received $40 million in milestone payments from Forest Laboratories Holdings Limited (NYSE: FRX) for MDX-8704. MDX-8704 is a fixed dosed combination (FDC) of Namenda XR(®) (memantine HCl extended release capsules) and donepezil HCl being developed as a once daily therapy for the treatment of moderate-to-severe dementia of the Alzheimer's type in the United States. The...

2013-11-21 23:19:32

Reportbuyer.com just published a new market research report: PharmaPoint: Alzheimer’s Disease - France Drug Forecast and Market Analysis to 2022. London (PRWEB) November 21, 2013 PharmaPoint: Alzheimer’s Disease - France Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Alzheimer’s Disease - France Drug Forecast and Market Analysis to 2022”. There are no long-term effective therapies for Alzheimer’s Disease (AD), so...

2013-11-12 23:20:13

Countervail’s advanced development contract with BARDA fully realized is valued at $24.9 million over a five year period. Sarin, Soman, VX, Tabun, and Cyclosarin are examples of extremely toxic organophosphorus based compounds created for use as chemical weapons. Charlotte, NC (PRWEB) November 12, 2013 CHARLOTTE, NC, Nov 8, 2013 /PRWeb/ -- Countervail Corporation announced today the Department of Health and Human Services (HHS), through the Biomedical Advanced Research and Development...

2013-10-29 23:21:16

Reportbuyer.com just published a new market research report: PharmaPoint: Alzheimer’s Disease - India Drug Forecast and Market Analysis to 2022. London (PRWEB) October 29, 2013 PharmaPoint: Alzheimer’s Disease - India Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Alzheimer’s Disease - India Drug Forecast and Market Analysis to 2022”. There are no long-term effective therapies for Alzheimer’s Disease (AD), so...

2013-10-24 23:18:56

Reportbuyer.com just published a new market research report: PharmaPoint: Alzheimer’s Disease - UK Drug Forecast and Market Analysis to 2022. London (PRWEB) October 24, 2013 PharmaPoint: Alzheimer’s Disease - UK Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Alzheimer’s Disease - UK Drug Forecast and Market Analysis to 2022”. There are no long-term effective therapies for Alzheimer’s Disease (AD), so this remains...

2013-10-24 23:04:24

Reportbuyer.com just published a new market research report: PharmaPoint: Alzheimer’s Disease - China Drug Forecast and Market Analysis to 2022. London (PRWEB) October 24, 2013 PharmaPoint: Alzheimer’s Disease - China Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Alzheimer’s Disease - China Drug Forecast and Market Analysis to 2022”. There are no long-term effective therapies for Alzheimer’s Disease (AD), so...


Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related